Antiemetic regimen with aprepitant in the prevention of chemotherapy-induced nausea and vomiting
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference70 articles.
1. Treatment of chemotherapy-induced emesis in the 1990 s: impact of the 5-HT3 receptor antagonists;Hesketh;Support Care Cancer,1994
2. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists;De Boer-Dennert;Br J Cancer,1997
3. The changeable nature of patients’ fears regarding chemotherapy: implications for palliative care;Passik;J Pain Symptom Manage,2001
4. Management of chemotherapy-induced nausea and vomiting:Focus on newer agents and new uses for older agents;Navari;Drugs,2013
5. Emerging treatments in chemotherapy-induced nausea and vomiting;Grunberg;Clin Adv Hematol Oncol,2013
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. After 20 Years of Treatment with Aprepitant for Chemotherapy-Induced Nausea and Vomiting, Should the Therapeutic Indications for Aprepitant be Expanded?;Pakistan Journal of Health Sciences;2024-06-30
2. The impact of Aprepitant on Nausea and Vomiting following Laparoscopic Sleeve Gastrectomy: A Blinded Randomized Controlled Trial;Obesity Surgery;2024-03-02
3. Efficacy and safety of Aprepitant-containing triple therapy for the prevention and treatment of chemotherapy-induced nausea and vomiting: A meta-analysis;Medicine;2023-11-24
4. An assessment of the effects of neurokinin1 receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug development;British Journal of Clinical Pharmacology;2023-08-17
5. Comparison of Anti-Emetic Efficacy of Granisetron and Dexamethasone Supplemented or not with Aprepitant During Hepatic Arterial Infusion Chemotherapy Against Hepatocellular Carcinoma: A Prospective Controlled Study;Eurasian Journal of Medicine and Oncology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3